Corrigendum to "Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors" [Bioorg. Med. Chem. 15 (2007) 1014-1021] (DOI:10.1016/j.bmc.2006.10.029);Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 2, 2007, Pages 1014-1021

  Zheng, Xiaoxia ^a   Oda, Hiroyuki ^a   Takamatsu, Kayo ^a   Sugimoto, Yukio ^a   Tai, Akihiro ^a   Akaho, Eiichi ^c   Ali, Hamed Ismail ^c   Oshiki, Toshiyuki ^b   Kakuta, Hiroki ^a   Sasaki, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Analgesic effects; COX 1 selective inhibitors; Cyclooxygenase 1; Docking study; Gastric damages; Molecular design; Structure activity relationship study; Sulfonamides

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; BENZENESULFONAMIDE DERIVATIVE; CYCLOOXYGENASE 1 INHIBITOR; FR 122047; INDOMETACIN; MOFEZOLAC;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; MALE; NONHUMAN; PAW EDEMA; RAT; SINGLE DRUG DOSE; STOMACH INJURY; WRITHING TEST;

EID: 33845336879     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.01.059     Document Type: Erratum

References (29)

1. Herschman H.R. Biochem. Biophys. Acta 1299 (1996) 125
2. Fu J.Y., Masferrer J.L., Seibert K., and Raz A. J. Biol. Chem. 265 (1990) 16737
3. Chandrasekharan N.V., Dai H., Roos K.L.T., Evanson N.K., Tomsik J., Elton T.S., and Simmons D.L. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13926
4. Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., and Russell R.I. N. Engl. J. Med. 327 (1992) 749
5. DeWitt D. Mol. Pharmacol. 55 (1999) 625
6. Kalagutkar A.S., and Zhao Z. Curr. Drug Targets 2 (2001) 79
7. Singh S.K., Vobbalareddy S., Shivaramakrishna S., Krishnamraj A., Rajjak S.A., Casturi S.R., Akhila V., and Rao Y.K. Bioorg. Med. Chem. Lett. 14 (2004) 1683
8. Habeeb A.G., PravennRao P.N., and Knaus E. J. Med. Chem. 44 (2001) 3039
9. Hu W.H., Guo Z.R., Chu F.M., Bai A.P., Yi X., Cheng G.F., and Li J. Bioorg. Med. Chem. 11 (2003) 1153
10. Prasit P., Wang Z., Brideau C., Chan C.C., Charleson S., Cromlish W., Ethier D., Evans J.F., Ford-Hutchinson A.W., Gauthier J.Y., Gordon R., Guay J., Gresser M., Kargman S., Kennedy B., Leblanc Y., Leger S., Mancini P., O'Neill G.P., Ouellet M., Percival M.D., Perrier H., Riendeau D., Rodger I., Tagari P., Therien M., Vickers P., Wong E., Xu L.J., Young R.N., and Zamboni R. Bioorg. Med. Chem. Lett. 9 (1999) 1773
11. Mukherjee D., Nissen S.E., and Topol E.J. JAMA 286 (2001) 954
12. Wallace J.L., McKnight W., Reuter B.K., and Vergnolle N. Gastroenterology 119 (2000) 706
13. Patrignani P., Filabozzi P., and Patrono C. J. Clin. Invest. 69 (1982) 1266
14. Kitamura T., Kawamori T., Uchiya N., Itoh M., Noda T., Matsuura M., Sugimura T., and Wakabayashi K. Carcinogenesis 23 (2002) 1463
15. Ochi T., Motoyama Y., and Goto T. Eur. J. Pharmacol. 391 (2000) 49
16. Daikoku T., Wang D., Tranguch S., Morrow J.D., Orsulic S., DuBois R.N., and Dey S.K. Cancer Res. 65 (2005) 3735
17. Gupta R.A., Tejada L.V., Tong B.J., Das S.K., Morrow J.D., Dey S.K., and DuBois R.N. Cancer Res. 63 (2003) 906
18. Sawaoka H., Tsuji S., Tsujii M., Gunawan E.S., Sasaki Y., Kawano S., and Hori M. Lab. Invest. 79 (1999) 1469
19. Jones M.K., Wang H., Peskar B.M., Levin E., Itani R.M., Sarfeh I.J., and Tarnawski A.S. Nat. Med. 5 (1999) 1418
20. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cell 93 (1998) 705
21. Giovannucci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., and Speizer F.E. N. Engl. J. Med. 333 (1995) 609
22. Schafer A.I. Am. J. Med. 106 (1999) 25S
23. Catella-Lawson F., Reilly M.P., Kapoor S.C., Cucchiara A.J., DeMarco S., Tournier B., Vyas S.N., and Fitzgerald G.A. N. Engl. J. Med. 345 (2001) 1809
24. Rerat P.B. Acta Cryst. B52 (1969) 1392
25. Adsmond D.A., and Grant D.J.W. J. Pharm. Sci. 90 (2001) 2058
26. For example. Casini A., Scozzafava A., Mastrolorenzo A., and Supuran C.T. Curr. Cancer Drug Targets 2 (2002) 55
27. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. J. Comput. Chem. 19 (1998) 1639
28. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., and Isakson P.C. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13313
29. Sano H., Noguchi T., Tanatani A., Hashimoto Y., and Miyachi H. Bioorg. Med. Chem. 13 (2005) 3079